Neuronetics Ownership
| STIM Stock | USD 1.40 -0.06 -4.11% |
Shares in Circulation | First Issued 2017-03-31 | Previous Quarter 67.3 M | Current Value 68.8 M | Average Shares Outstanding 25.5 M | Quarterly Volatility 17.4 M |
Macro event markers
Institutional investors typically maintain specialized teams focused on research and data analysis. This category encompasses banks, hedge funds, insurance organizations, and pension-related entities.
Neuronetics | Build portfolio with Neuronetics Stock |
Stock Ownership Analysis
About 30.0% of the company outstanding shares are owned by corporate insiders. The book value of Neuronetics was at this time reported as 0.32. The company recorded a loss per share of 0.59. Neuronetics had not issued any dividends in recent years.Stock Institutional Investors
Neuronetics has 64.40% institutional ownership and 29.50% insider stake. Annual revenue is about 149.16 Million. This mix shapes how the stock trades around earnings. The business currently sits in the Health Care sector and the Health Care Equipment & Services industry. Short interest and volume patterns add useful context given the ownership split.
| Shares | Ikarian Capital, Llc | 2025-12-31 | 701.2 K | State Street Corp | 2025-09-30 | 587.6 K | Hightower Advisors, Llc | 2025-12-31 | 564.3 K | Morgan Stanley - Brokerage Accounts | 2025-09-30 | 475.7 K | Renaissance Technologies Corp | 2025-12-31 | 474.9 K | Susquehanna International Group, Llp | 2025-12-31 | 321.6 K | Xtx Topco Ltd | 2025-12-31 | 314.2 K | Marshall Wace Asset Management Ltd | 2025-12-31 | 286 K | Northern Trust Corp | 2025-09-30 | 276.6 K | Madryn Asset Management, Lp | 2025-12-31 | 18.5 M | Vanguard Group Inc | 2025-12-31 | 2.6 M |
Insider Trading Activities
Tracking Neuronetics' insider filings adds context. Executives often respond to business conditions well before market sentiment shifts. Most U.S. insider trades appear in Form 4 filings. The value comes from reading the sequence, not one filing in isolation.
Outstanding Bonds
Outstanding bonds linked to Neuronetics can tell investors a great deal about how the company finances itself beyond common equity markets. Maturity profile, refinancing windows, and coupon burden can all affect how resilient the capital structure looks in a weaker market.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try Portfolio Prophet